Hypertension and cognitive functioning: A perspective in historical context

Hypertension

Volumn 60, Issue 2, 2012, Pages 260-268

  Elias, Merrill F ^a,b   Goodell, Amanda L ^a   Dore, Gregory A ^a  

^a University of Maine   (United States)

^b UNIVERSITY OF MAINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN DAMAGE; BRAIN REGION; CASE STUDY; CLINICAL PRACTICE; COGNITION; DEMENTIA; DESCRIPTIVE RESEARCH; HUMAN; HYPERTENSION; MILD COGNITIVE IMPAIRMENT; PATIENT CARE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROSPECTIVE STUDY; PUBLICATION; TASK PERFORMANCE; VISUAL MEMORY;

ANTIHYPERTENSIVE AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 84864287773     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.186429     Document Type: Article

References (70)

1. Kotchen TA. Historical trends and milestones in hypertension research: A model of the process of translational research. Hypertension. 2011;58: 522-538.
2. Elias MF, Robbins MA, Budge MM, Elias PK, Hermann BA, Dore GA. Studies of aging, hypertension and cognitive functioning: With contributions from the Maine-Syracuse Study. In: Mattson MP, series ed, and Costa PT, Siegler IC, vol ed. Advances in Cell Aging and Gerontology, Vol. 14: Recent Advances in Psychology and Aging. Amsterdam, The Netherlands: Elsevier; 2004:89-131. (Pubitemid 137640668)
3. Jennings JR, Zanstra Y. Is the brain essential in hypertension? NeuroImage. 2009;47:914-921.
4. Manolio TA, Olson J, Longstreth WT. Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep. 2003;5:255-261. (Pubitemid 38914969)
5. Waldstein SR. Hypertension and neuropsychological function: A lifespan perspective. Exp Aging Res. 1995;21:321-352.
6. Staessen JA, Richart T, Birkenhäger WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension. 2007;49:389-400.
7. Waldstein SR, Manuck SB, Ryan CM, Muldoon MF. Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull. 1991;110:451-468.
8. Waldstein SR. The relation of hypertension to cognitive function. Curr Dir Psychol Sci. 2003;12:9-12. (Pubitemid 36742622)
9. Kennelly SP, Lawlor BA, Kenny RA. Blood pressure and the risk for dementia: A double edged sword. Ageing Research Reviews. 2009;8: 61-70.
10. Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Rsk Manag. 2008;4:395-402. (Pubitemid 351711967)
11. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, IV ed. New York, NY: Oxford University Press; 2004.
12. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation.Tucson, AZ: Neuropsychology Press; 1993.
13. Rabbitt P. Introduction: methodologies and models in the study of executive function. In: Rabbitt P, ed. Methodology of Frontal and Executive Function.Hove, East Essex, UK: Psychology Press; 1998:1-35.
14. Raz N, Rodrigue KM, Acker JD. Hypertension and the brain: Vulnerability of the prefrontal regions and executive functions. Behav Neurosci. 2003;117:1169-1180. (Pubitemid 37549420)
15. Haier RJ, Schroeder DH, Tang C, Head K, Colom R. Gray matter correlates of cognitive ability tests used for vocational guidance. BMC Res Notes. 2010;3:206-212.
16. Apter NS, Halstead WC, Heimburger RF. Impaired cerebral functions in essential hypertension. Am J Psychiatry. 1951;11:808-813.
17. Reitan RM. Intellectual and affective changes in essential hypertension. Am J Psychiatry. 1954;110:817-824.
18. Elias MF, Robbins MA, Schultz NR Jr, Streeten DHP, Elias PK. Clinical significance of cognitive performance by hypertensive patients. Hypertension. 1987;9:192-197. (Pubitemid 17027834)
19. Spieth W. Cardiovascular health status, age, and psychological performance. J Gerontol. 1964;19:277-284.
20. Waldstein SR, Katzel LI. Hypertension and cognitive function. In: Waldstein S, Elias MF, ed. Neuropsychology of Cardiovascular Disease-.Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.; 2001:15-36.
21. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:959-962.
22. Hagberg BO, Ingvar DH. Cognitive reduction in presenile dementia related to regional abnormalities of the cerebral blood flow. Brit J Psychiat. 1976;128:209-222.
23. Jagust WJ, Eberling JL, Reed BR, Mathis CA, Budinger TF. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann NY Acad Sci. 1997;826:254-262. (Pubitemid 27478047)
24. Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, van der Veen FM, Meltzer CC. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology. 2005;64:1358-1365. (Pubitemid 40570501)
25. Elias PK, D'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension and age as risk factors for poor cognitive performance. Exp Aging Res. 1995;21:393-417.
26. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, Wolf PA. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care. 1997;20: 1388-1395. (Pubitemid 27366813)
27. Elias MF, Elias PK, Dore GA, Robbins MA. High-normal blood pressure and cognition: supplying the missing data. Hypertension. 2008;52:el-e2.
28. Elias MF, Robbins MA, Elias PK, Streeten DHP. A longitudinal study of blood pressure in relation to performance on the Wechsler Adult Intelligence Scale. Health Psychol. 1998;17:486-493. (Pubitemid 28541530)
29. Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: Does age make a difference? Hypertension. 2004;44: 631-636. (Pubitemid 39435231)
30. Robbins MA, Elias MF, Elias PK, Budge MM. Blood pressure and cognitive function in an African-American and a Caucasian-American sample: The Maine-Syracuse Study. Psychosom Med. 2005;67:707-714. (Pubitemid 41396016)
31. Tin LL, Beevers DG, Lip GYH. Systolic vs diastolic blood pressure and the burden of hypertension. J Hum Hypertens. 2002;16:147-150. (Pubitemid 34232533)
32. Lande MB, Kaczorowski JM, Auinger P, Schwartz GJ, Weitzman M. Elevated blood pressure and decreased cognitive function among school-Age children and adolescents in the United States. J Pediatr. 2003;143:720-724. (Pubitemid 37510638)
33. Sharma M, Kupferman JC, Brosgol Y, Paterno K, Goodman S, Prohovnik I, Kirkham FJ, Pavlakis SG. The effects of hypertension on the paediatric brain: A justifiable concern. Lancet Neurol. 2010;9:933-940.
34. Pentz CA III, Elias MF, Wood WG, Schultz NA, Dineen J. Relationship of age and hypertension to neuropsychological test performance. Exp Aging Res. 1979;5:351-372. (Pubitemid 9253843)
35. Farmer ME, White LR, Abbott RD, Kittner SJ, Kaplan E, Wolz MM, Brody JA, Wolf PA. Blood pressure and cognitive performance: The Framingham Study. Am J Epidemiol. 1987;126:1103-1014.
36. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol. 1993;138:353-364. (Pubitemid 23289288)
37. Farmer ME, Kittner SJ, Abbott RD, Wolz MM, Wolf PA, White LR. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: The Framingham Study. J Clin Epidemiol. 1990;43:475-480. (Pubitemid 20153148)
38. Launer LJ. The epidemiologic study of dementia: A life-long quest? Neurobiol Aging. 2005;26:335-340. (Pubitemid 40082716)
39. Launer LJ, Masaki K, Petrovitch H. Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function: The Honolulu Asia-Aging Study. JAMA. 1995;274:1846-1851. (Pubitemid 26001260)
40. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. Midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurobiol Aging. 2000;21:49-55. (Pubitemid 30224785)
41. Kilander L, Nyman H, Boberg M, Hansson L. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension. 1998;31:780-786. (Pubitemid 28108576)
42. Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension. 2008;51: 99-104. (Pubitemid 350307110)
43. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: The Framingham Heart Study. Int J Obes Relat Metab Disord. 2003;27:260-268. (Pubitemid 36255810)
44. Crichton GE, Elias MF, Buckley J, Murphy KJ, Bryan J, Frisardi V. Metabolic syndrome, cognitive performance and dementia. J Alzheimers Dis. 2012;30(Suppl. 2):S577-S587.
45. Guo Z, Fratiglioni L, Vittanen M, Lannfelt L, Basun H, Fastbom J, Winblad B. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? Am J Epidemiol. 2001;153:225-231. (Pubitemid 32958646)
46. Strassburger TL, Lee HC, Daly EM, Szczepanik J, Krasuski JS, Mentis MJ, Salerno JA, DeCarli C, Schapiro MB, Alexander GE. Interactive effects of age and hypertension on volumes of brain structures. Stroke. 1997;28:1410-1417. (Pubitemid 27300680)
47. Kochunov P, Glahn DC, Lancaster J, Winkler A, Karlsgodt K, Olvera RL, Curran JE, Carless MA, Dyer TD, Almasy L, Duggirala R, Fox PT, Blangero J. Blood pressure and cerebral white matter share common genetic factors in Mexican Americans. Hypertension. 2011;57:330-335.
48. Gunstad J, Benitez A, Hoth KF, Spitznagel MB, McCaffery J, McGeary J, Kakos LS, Poppas A, Paul RH, Jefferson AL, Sweet LH, Cohen RA. P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Stroke. 2009;40:2969-2972.
49. Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: The Baltimore Longitudinal Study of Aging. Hypertension. 2005;45:374-379. (Pubitemid 40315806)
50. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke. 1998;29: 2334-2340. (Pubitemid 28511954)
51. Insel KC, Palmer RF, Sroup-Benham CA, Markides KS, Espino DV. Association between change in systolic blood pressure and cognitive decline among elderly Americans: data from the Hispanic Established Population for Epidemiology Study of the Elderly. Exp Aging Res. 2005; 31:35-54. (Pubitemid 40069910)
52. Kuo H-K, Jones RN, Milberg WP, Tennstedt S, Talbot L, Morris JN, Lipsitz LA. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: A longitudinal analysis of the Advances Cognitive Training for Independent and Vital Elderly cohort. J Am Geriatr Soc. 2005;53:1154-1161. (Pubitemid 41632516)
53. Hajjar I, Catoe H, Sixta S, Boland R, Johnson D, Hirth V, Wieland D, Eleazer P. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci. 2005;60:67-73. (Pubitemid 40321860)
54. Knopman DS, Mosley TH, Catellier DJ, Coker LH, for the Atherosclerosis Risk in Communities Study Brain MRI Study. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement. 2009;5:207-214.
55. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145. (Pubitemid 126512042)
56. Hassing LB, Hofer SM, Nilsson SE, Berg S, Pedersen NL, McClearn G, McClearn G. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: Evidence from a longitudinal study. Age Ageing. 2004;33:355-361. (Pubitemid 39077242)
57. Hebert LE, Scherr PA, Bennett DA, Bienias JL, Wilson RS, Morris MC, Evans DA. Blood pressure and late-life cognitive function change. Neurology. 2004;62:2021-2024.
58. Clair D, Whalley LJ. Hypertension, multi-infarct dementia and Alzheimer's disease. Br J Psychiat. 1983;143:274-276. (Pubitemid 13038405)
59. Stewart R. Cardiovascular factors in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1998;65:143-147. (Pubitemid 28371919)
60. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154. (Pubitemid 27039193)
61. Reitz C, Tang MX, Manly J, Mayeux R, Luchsinger JA. Hypertension and the risk of mild cognitive impairment. Arch Neurol. 2007;64: 1734-1740. (Pubitemid 350254935)
62. Oveisgharan S, Hachinski V. Hypertension, executive dysfunction, and progression to dementia: The Canadian Study of Health and Aging. Arch Neurol. 2010;67:187-192.
63. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ. 1996;312:801-805. (Pubitemid 26099297)
64. Cervilla JA, Prince M, Joels S, Lovestone S, Mann A. Long-term prediction of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry. 2000;177:66-71. (Pubitemid 30450667)
65. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM Jr, Schron E, Wegener V. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program. Arch Intern Med. 1994;154:2154-2160. (Pubitemid 24317261)
66. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352: 1347-1351. (Pubitemid 28510916)
67. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH; Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med. 2002;162:2046-2052. (Pubitemid 35168212)
68. Staessen JA, Thijs L, Richart T, Odili AN, Birkenhäger WH. Placebocontrolled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension. 2011;57:e6-e7.
69. Peters R, Beckett N. Hypertension, dementia, and antihypertensive treatment: Implications for the very elderly. Curr Hypertens Rep. 2009;11:277-282.
70. Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, Strauman TA, Sherwood A. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55:1331-1338.